About Us
Businesses
Our Impact
News
Insights
Investors
Careers
My Account
Home
/
Insights
/
All Insights
Technology & Innovation
How is AI Revolutionizing Drug Discovery?
Video
•
December 12, 2023
Adam Spielman, Head of Health, Citi Global Insights and Andrew Hopkins, Founder and CEO, Exscientia discuss how AI impacts biopharma, including the extent to which AI is a threat to traditional biopharma companies, and how they should respond.
Related Stories
Technology & Innovation
AI in Healthcare: How will AI Change the Role of Clinicians?
In conversation with Munjal Shah, CEO - HippocraticAI.
Technology & Innovation
AI in Healthcare: Health Administration
A recent report from Adam Spielman of Citi Global Insights looks at the possibilities for AI to impact health administration, potentially cutting costs and helping ease the huge burden on clinicians.
Technology & Innovation
AI in Healthcare: Are AI Doctors on Call?
Citi’s Adam Spielman is the author of a series of reports on the impact of AI on the healthcare sector. Here he discusses several aspects of his research including AI’s impact on clinicians, its potential to drastically lessen their administrative burden, and why biopharma could be the area that AI impacts most of all.
Sign up to receive the latest from Citi.
Next